Expect Equity LLC Has $2.84 Million Position in The Cooper Companies, Inc. $COO

Expect Equity LLC lifted its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 29.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 34,620 shares of the medical device company’s stock after acquiring an additional 7,790 shares during the quarter. Cooper Companies makes up about 2.7% of Expect Equity LLC’s investment portfolio, making the stock its 12th largest position. Expect Equity LLC’s holdings in Cooper Companies were worth $2,837,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in COO. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of Cooper Companies by 48.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 22,407 shares of the medical device company’s stock worth $1,890,000 after acquiring an additional 7,363 shares during the last quarter. First Trust Advisors LP raised its position in shares of Cooper Companies by 115.8% during the second quarter. First Trust Advisors LP now owns 136,334 shares of the medical device company’s stock worth $9,702,000 after acquiring an additional 73,165 shares during the last quarter. Cresset Asset Management LLC bought a new stake in Cooper Companies in the second quarter valued at about $291,000. Cerity Partners LLC increased its holdings in Cooper Companies by 4.4% in the second quarter. Cerity Partners LLC now owns 17,870 shares of the medical device company’s stock valued at $1,272,000 after purchasing an additional 757 shares during the last quarter. Finally, Daiwa Securities Group Inc. increased its holdings in Cooper Companies by 2.8% in the second quarter. Daiwa Securities Group Inc. now owns 35,839 shares of the medical device company’s stock valued at $2,551,000 after purchasing an additional 973 shares during the last quarter. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Down 3.4%

Shares of Cooper Companies stock opened at $65.05 on Thursday. The Cooper Companies, Inc. has a 1 year low of $58.89 and a 1 year high of $89.83. The business has a 50-day moving average of $64.58 and a two-hundred day moving average of $74.10. The company has a market capitalization of $12.69 billion, a P/E ratio of 55.13, a price-to-earnings-growth ratio of 1.76 and a beta of 0.87. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.10 by $0.11. The company had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The company’s revenue for the quarter was up 7.9% compared to the same quarter last year. During the same period in the prior year, the company earned $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, equities analysts predict that The Cooper Companies, Inc. will post 4.63 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the company. Barclays upped their price objective on Cooper Companies from $98.00 to $103.00 and gave the company an “overweight” rating in a report on Friday, March 6th. Mizuho set a $85.00 price objective on Cooper Companies and gave the company an “outperform” rating in a report on Thursday, June 4th. Piper Sandler set a $86.00 price objective on Cooper Companies and gave the company an “overweight” rating in a report on Monday, June 1st. Needham & Company LLC dropped their price objective on Cooper Companies from $101.00 to $86.00 and set a “buy” rating for the company in a report on Friday, June 5th. Finally, BNP Paribas Exane dropped their price objective on Cooper Companies from $95.00 to $92.00 and set an “outperform” rating for the company in a report on Monday, June 8th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have assigned a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $81.31.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.